MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin

92Citations
Citations of this article
62Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

It has been reported that persistent or excessive autophagy promotes cancer cell death during chemotherapy, either by enhancing the induction of apoptosis or mediating autophagic cell death. Here, we show that miR-15a and miR-16 are potent inducers of autophagy. Rictor, a component of mTORC2 complex, is directly targeted by miR-15a/16. Overexpression of miR-15a/16 or depletion of endogenous Rictor attenuates the phosphorylation of mTORC1 and p70S6K, inhibits cell proliferation and G1/S cell cycle transition in human cervical carcinoma HeLa cells. Moreover, miR-15a/16 dramatically enhances anticancer drug camptothecin (CPT)-induced autophagy and apoptotic cell death in HeLa cells. Collectively, these data demonstrate that miR-15a/16 induced autophagy contribute partly to their inhibition of cell proliferation and enhanced chemotherapeutic efficacy of CPT.

Cite

CITATION STYLE

APA

Huang, N., Wu, J., Qiu, W., Lyu, Q., He, J., Xie, W., … Zhang, Y. (2015). MiR-15a and miR-16 induce autophagy and enhance chemosensitivity of Camptothecin. Cancer Biology and Therapy, 16(6), 941–948. https://doi.org/10.1080/15384047.2015.1040963

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free